| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the National Institute of Allergy and Infectious Diseases* and the Division of Veterinary Resources, Office of Research Services, National Institutes of Health, Bethesda, Maryland; and the Department of Medicine and Ben May Institute for Cancer Research, The University of Chicago, Chicago, Illinois
Bacillus anthracis edema toxin (ET), an adenylyl cyclase, is an important virulence factor that contributes to anthrax disease. The role of ET in anthrax pathogenesis is, however, poorly understood. Previous studies using crude toxin preparations associated ET with subcutaneous edema, and ET-deficient strains of B. anthracis showed a reduction in virulence. We report the first comprehensive study of ET-induced pathology in an animal model. Highly purified ET caused death in BALB/cJ mice at lower doses and more rapidly than previously seen with the other major B. anthracis virulence factor, lethal toxin. Observations of gross pathology showed intestinal intralumenal fluid accumulation followed by focal hemorrhaging of the ileum and adrenal glands. Histopathological analyses of timed tissue harvests revealed lesions in several tissues including adrenal glands, lymphoid organs, bone, bone marrow, gastrointestinal mucosa, heart, and kidneys. Concomitant blood chemistry analyses supported the induction of tissue damage. Several cytokines increased after ET administration, including granulocyte colony-stimulating factor, eotaxin, keratinocyte-derived cytokine, MCP-1/JE, interleukin-6, interleukin-10, and interleukin-1ß. Physiological measurements also revealed a concurrent hypotension and bradycardia. These studies detail the extensive pathological lesions caused by ET and suggest that it causes death due to multiorgan failure.
This article has been cited by other articles:
 |
|
 |
|
  M. Moayeri, T. M. Robinson, S. H. Leppla, and V. A. Karginov In Vivo Efficacy of {beta}-Cyclodextrin Derivatives against Anthrax Lethal Toxin Antimicrob. Agents Chemother., June 1, 2008; 52(6): 2239 - 2241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Bolcome III, S. E. Sullivan, R. Zeller, A. P. Barker, R. J. Collier, and J. Chan Anthrax lethal toxin induces cell death-independent permeability in zebrafish vasculature PNAS, February 19, 2008; 105(7): 2439 - 2444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. J. Glomski, J.-P. Corre, M. Mock, and P. L. Goossens Noncapsulated Toxinogenic Bacillus anthracis Presents a Specific Growth and Dissemination Pattern in Naive and Protective Antigen-Immune Mice Infect. Immun., October 1, 2007; 75(10): 4754 - 4761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-D. Ha, D. Ng, J. Lamothe, M. A. Valvano, J. Han, and S. O. Kim Mitochondrial Proteins Bnip3 and Bnip3L Are Involved in Anthrax Lethal Toxin-induced Macrophage Cell Death J. Biol. Chem., September 7, 2007; 282(36): 26275 - 26283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Sanchez, D. Thomas, E. J. Gillespie, R. Damoiseaux, J. Rogers, J. P. Saxe, J. Huang, M. Manchester, and K. A. Bradley Amiodarone and Bepridil Inhibit Anthrax Toxin Entry into Host Cells Antimicrob. Agents Chemother., July 1, 2007; 51(7): 2403 - 2411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Firoved, M. Moayeri, J. F. Wiggins, Y. Shen, W.-J. Tang, and S. H. Leppla Anthrax Edema Toxin Sensitizes DBA/2J Mice to Lethal Toxin Infect. Immun., May 1, 2007; 75(5): 2120 - 2125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tessier, C. Green, D. Padgett, W. Zhao, L. Schwartz, M. Hughes, and E. Hewlett Contributions of Histamine, Prostanoids, and Neurokinins to Edema Elicited by Edema Toxin from Bacillus anthracis Infect. Immun., April 1, 2007; 75(4): 1895 - 1903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Geny, H. Khun, C. Fitting, L. Zarantonelli, C. Mazuet, N. Cayet, M. Szatanik, M.-C. Prevost, J.-M. Cavaillon, M. Huerre, et al. Clostridium sordellii Lethal Toxin Kills Mice by Inducing a Major Increase in Lung Vascular Permeability Am. J. Pathol., March 1, 2007; 170(3): 1003 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sherer, Y. Li, X. Cui, and P. Q. Eichacker Lethal and Edema Toxins in the Pathogenesis of Bacillus anthracis Septic Shock: Implications for Therapy Am. J. Respir. Crit. Care Med., February 1, 2007; 175(3): 211 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Heninger, M. Drysdale, J. Lovchik, J. Hutt, M. F. Lipscomb, T. M. Koehler, and C. R. Lyons Toxin-Deficient Mutants of Bacillus anthracis Are Lethal in a Murine Model for Pulmonary Anthrax Infect. Immun., November 1, 2006; 74(11): 6067 - 6074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Stearns-Kurosawa, F. Lupu, F. B. Taylor Jr., G. Kinasewitz, and S. Kurosawa Sepsis and Pathophysiology of Anthrax in a Nonhuman Primate Model Am. J. Pathol., August 1, 2006; 169(2): 433 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Keim, M. Mock, J. Young, and T. M. Koehler The International Bacillus anthracis, B. cereus, and B. thuringiensis Conference, "Bacillus-ACT05". J. Bacteriol., May 1, 2006; 188(10): 3433 - 3441. [Full Text] [PDF]
|
|
|
|
|
|
A. Guichard, J. M. Park, B. Cruz-Moreno, M. Karin, and E. Bier From The Cover: Anthrax lethal factor and edema factor act on conserved targets in Drosophila PNAS, February 28, 2006; 103(9): 3244 - 3249. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
